Drug Name:
DIGESTIVE ADVANTAGE IRRITABLE BOWEL SYNDROME OTC
Generic Name and Formulations:
GanedenBC30 (Bacillus coagulans GBI-30, 6086), lysine; vegetarian caps; lactose-free; may contain trace amounts of casein (milk protein).
Company:
Ganeden Biotech
Therapeutic Use:
Indications for DIGESTIVE ADVANTAGE IRRITABLE BOWEL SYNDROME:
For the daily dietary management of IBS symptoms.
Adult:
Capsules may be opened and contents sprinkled into food or drink. 1 capsule daily. Max 2 caps/daily.
Children:
Capsules may be opened and contents mixed into cold drink, oatmeal, applesauce or other food. 1 capsule daily.
Interactions:
Antagonized by antibiotics.
Pharmacological Class:
Probiotic.
Adverse Reactions:
Gas, bloating.
How Supplied:
Caps—32
Endocrinology Advisor Articles
- Soluble Klotho Levels Predictive of Kidney Failure in Type 2 Diabetes
- Clinicians May Be Overtreating Older Patients With Diabetes
- Comorbid and Pharmacologic Factors Increase Risk for Gastrointestinal Disorders in Diabetes
- Obesity Risk in Infants Born to Women With Diabetes
- Increased Risk for Mortality in People With Diabetes, CHD Taking Beta-Blockers
- Diabetes May Decrease Ability to Feel Acid Regurgitation
- Autism Does Not Affect Metabolic Control in Type 1 Diabetes
- Hormonal Contraceptives May Adversely Affect Psychological Health in Adolescent Girls
- Obesity Can Negatively Effect Liver in Children as Young as 8
- Recommendations Developed on Gender Equity in Medicine
Sign Up for Free e-Newsletters
Check out what's trending
CME Focus
Contemporary Management of Type 2 Diabetes
CME
1.00 Credits